Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

European regulator recommends approving GSK injectable asthma drug

GlaxoSmithKline Plc said the European health regulator had recommended approving its injectable drug to treat asthma patients who don’t respond well to traditional inhalers. The European Commission is expected to decide on a final approval for the drug before the end of 2015. The European Medicines Agency’s Committee for Medicinal Products for Human Use gives […]

Read More »

Novartis launches portfolio for low and low-middle-income countries

Novartis AG launched a portfolio of 15 medicines to treat chronic diseases in low- and low-middle-income countries, the drugmaker said in a statement on Thursday.   The Basel-based company said ‘Novartis Access’ will be launched first in Kenya, Ethiopia and Vietnam, with expansion to eventually include 30 countries. Novartis said the portfolio addresses cardiovascular diseases, […]

Read More »

Nobel Prize predictions see honors for gene editing technology

Scientists behind the discovery of a technology called CRISPR-Cas9 that allows researchers to edit virtually any gene they target are among the top contenders for Nobel prizes next month, according to an annual analysis by Thomson Reuters. The predictions announced on Thursday come from the Intellectual Property & Science unit of Thomson Reuters (which also […]

Read More »

Pfizer’s Sayana Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection

Builds on Current Momentum Towards Broadening Access to This Contraceptive Option for Women Across the Globe   September 24, 2015 12:01 AM Eastern Daylight Time   NEW YORK–(BUSINESS WIRE)–Pfizer Inc. announced today that the company’s injectable contraceptive, Sayana® Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for administration by self-injection. […]

Read More »

Weight-loss surgery may not increase health costs for diabetes

(Reuters Health) – Weight loss surgery may be a cost-effective way of lowering blood sugar for many diabetics, not just those who are severely obese, a Swedish study suggests.   Researchers found that for people with diabetes, total healthcare costs did not rise in the years following weight-loss surgery, largely because of overall savings from […]

Read More »

Non-antibotic drug shows promise in deadly C. difficile infections

A non-antibiotic drug already tested in people for other uses may be active in treating Clostridium difficile, a superbug that preys on people whose protective gut bacteria have been wiped out by antibiotics. Studies in mice by researchers at Stanford University School of Medicine showed that the drug ebeselen, a compound being studied in clinical […]

Read More »

Steep discounts help biotech drug copies gain ground in Europe

LONDON (Reuters) – Cut-price versions of expensive biotech drugs are gaining ground in Europe, following surprisingly steep price discounts offered on the first copy of a complex antibody medicine for rheumatoid arthritis and Crohn’s disease. The potential for so-called “biosimilars” to take business from pricey original brands is grabbing the attention of both healthcare providers, […]

Read More »

Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215

Study Evaluated Efficacy and Safety of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-small Cell Lung Cancer Primary Efficacy Analysis Demonstrates Clinical Equivalence; Safety, Immunogenicity Comparable to Bevacizumab   THOUSAND OAKS, Calif. and DUBLIN, Sept. 23, 2015 /PRNewswire/ — Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) today announced a Phase 3 study […]

Read More »

OncoGenex’s pancreatic cancer drug found ineffective in study

(Reuters) – Drug developer OncoGenex Pharmaceuticals Inc said its experimental combination therapy for pancreatic cancer was not effective in a mid-stage study. The intravenous drug, apatorsen, when added to Celgene Corp’s combination treatment of Abraxane and chemotherapy drug gemcitabine, did not show any survival benefit when compared with the Abraxane combination alone, OncoGenex said. The […]

Read More »

Nestle pushes further into medicine with planned Alzheimer’s test

ZURICH (Reuters) – Food group Nestle has taken a further step into the medicine business by signing a research collaboration agreement with a Swiss biotech company to develop an Alzheimer’s disease diagnostic test. Nestle’s second medical deal in a week underscores the commitment by the world’s largest packaged food company to the faster-growing, more profitable […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom